Press release from CNW Group
TSO3 to Disclose First Quarter 2013 Financial Results and Hold Annual General Meeting of Shareholders May 8, 2013
Monday, April 29, 2013
TSO3 to Disclose First Quarter 2013 Financial Results and Hold Annual General Meeting of Shareholders May 8, 201306:30 EDT Monday, April 29, 2013
Ticker: TSX - TOS
Shares Outstanding: 72,888,182
QUEBEC CITY, April 29, 2013 /CNW Telbec/ - TSO3 Inc. ("TSO3") (TSX: TOS) will report first quarter (Q1) 2013 financial results, for the period ending March 31, 2013 via press release on Wednesday May 8, 2013. TSO3 will also hold its fiscal 2012 Annual General Meeting of Shareholders at 3:00 P.M. (EDST) the same day.
The Annual General Meeting of Shareholders will be held at the McCord Museum (J. Armand-Bombardier Theatre), 690 Sherbrooke Street West, Montreal (Québec) at 3:00 P.M. (EDST).
Interested parties will be able to listen to the live webcasts of the Annual General Meeting of Shareholders via CNW's website at http://www.newswire.ca/en/webcast/detail/1135279/1238559. The webcast will then be archived for a 90-day period.
TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. TSO3 designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used in hospitals. For more information about TSO3, visit the Company's Web site at www.tso3.com
The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.
The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.
SOURCE: TSO3 Inc.
For further information:
Director - Investor and Business Relations
418 651-0003, Ext. 237